Cargando…
Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers
SIMPLE SUMMARY: In search of genetic factors that affect cancer risks in BRCA carriers, we carried out the first whole-genome sequencing study in a unique registry of familial ovarian cancer, selected to enrich with BRCA1/2 carriers. We are the first to survey rare variants, particularly the non-cod...
Autores principales: | Zhu, Qianqian, Wang, Jie, Yu, Han, Hu, Qiang, Bateman, Nicholas W., Long, Mark, Rosario, Spencer, Schultz, Emily, Dalgard, Clifton L., Wilkerson, Matthew D., Sukumar, Gauthaman, Huang, Ruea-Yea, Kaur, Jasmine, Lele, Shashikant B., Zsiros, Emese, Villella, Jeannine, Lugade, Amit, Moysich, Kirsten, Conrads, Thomas P., Maxwell, George L., Odunsi, Kunle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139302/ https://www.ncbi.nlm.nih.gov/pubmed/35625955 http://dx.doi.org/10.3390/cancers14102350 |
Ejemplares similares
-
Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
por: Zhu, Qianqian, et al.
Publicado: (2019) -
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8(+) T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
por: Huang, Ruea-Yea, et al.
Publicado: (2015) -
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study
por: Eng, Kevin H., et al.
Publicado: (2018) -
Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
por: Odunsi, Kunle, et al.
Publicado: (2012) -
Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer
por: Want, Muzamil Yaqub, et al.
Publicado: (2019)